Compare Eli Lilly And Co (LLY) vs Utilities Select Sector SPDR Fund (XLU) Price & Performance

Eli Lilly (LLY) trades at $1,150.86, down 2.39% on the day, with a bullish technical signal from moving averages and strong fundamental performance. The company reported robust earnings beats in recent quarters, with Q1 2026 EPS of $8.55 exceeding expectations by 23%. Revenue surged to $65.18 billion in 2025, driving a net income margin of 34.99%. Recent news highlights LLY's $2.8 billion acquisition of AtaiBeckley to expand its neuroscience pipeline, signaling strategic growth in mental health treatments.

Outlook remains positive with analyst consensus price target of $1,380 implying 20% upside, supported by 73% buy ratings. Key risks include high valuation multiples (P/E 41.89) and rising debt levels, though operating cash flow growth to $16.81 billion in 2025 provides financial flexibility. Investors should monitor Q2 2026 earnings on August 5 for continued execution on weight-loss drug demand and integration of recent acquisitions.

XLU trades at $44.93, down 0.51% on the day, with a bearish technical signal from moving averages while oscillators remain neutral. The ETF benefits from growing AI-driven electricity demand, highlighted by recent news of utility stocks gaining traction as data center power needs strain the grid. Support sits at $44, with resistance at $46.

Outlook is cautiously optimistic due to structural power demand tailwinds from AI and clean energy transitions, though regulatory risks and execution challenges pose headwinds. The ETF offers defensive exposure with dividend income, but investors should monitor utility sector capacity investments and interest rate sensitivity.